• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

癌症患者使用双膦酸盐类药物导致的非典型股骨骨折——综述

Atypical femoral fractures from bisphosphonate in cancer patients - Review.

作者信息

Lockwood Matthew, Banderudrappagari Rajesh, Suva Larry J, Makhoul Issam

机构信息

Division of Hematology/Oncology, Department of Internal Medicine, University of Arkansas for Medical Sciences, 4301 West Markham, Little Rock, AR, 72205, USA.

Department of Veterinary Physiology and Pharmacology, College of Veterinary Medicine and Biomedical Sciences, Texas A&M University, 4466 TAMU, College Station, TX, 77843-4466, USA.

出版信息

J Bone Oncol. 2019 Aug 22;18:100259. doi: 10.1016/j.jbo.2019.100259. eCollection 2019 Oct.

DOI:10.1016/j.jbo.2019.100259
PMID:31497503
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6722257/
Abstract

Bisphosphonates are commonly used in patients with metastatic bone disease to prevent skeletal related events. Atypical femur fracture is a known complication of long-term bisphosphonate use but the incidence in cancer patients and pathogenesis are not well known. Several mechanisms of pathogenesis have been proposed including altered angiogenesis, altered bone mechanical properties, micro damage and bone remodeling suppression. Atypical femur fractures are atraumatic or minimally traumatic fractures in the sub trochanteric region or the femoral shaft. Awareness of atypical femur fractures is critical to diagnose and treat them in a timely manner. There is a paucity of data regarding the management of atypical femur fracture in patients with malignancy. Management options of atypical femur fractures include stopping bisphosphonates, initiating calcium/vitamin D supplementation and either surgery with internal fixation or conservative management. In the future, it will be important to explore the effect of continuous vs. intermittent exposure, cumulative dose and length of exposure on the incidence of this complication. Herein, we review the epidemiology, risk factors, management options and proposed mechanisms of pathogenesis of atypical femur fractures.

摘要

双膦酸盐常用于转移性骨病患者以预防骨相关事件。非典型股骨骨折是长期使用双膦酸盐已知的并发症,但癌症患者中的发生率及发病机制尚不清楚。已提出多种发病机制,包括血管生成改变、骨力学性能改变、微损伤及骨重塑抑制。非典型股骨骨折是转子下区域或股骨干的无创伤或微创伤骨折。认识非典型股骨骨折对于及时诊断和治疗至关重要。关于恶性肿瘤患者非典型股骨骨折的治疗,数据匮乏。非典型股骨骨折的治疗选择包括停用双膦酸盐、开始补充钙/维生素D以及手术内固定或保守治疗。未来,探究持续暴露与间歇暴露、累积剂量及暴露时长对该并发症发生率的影响将很重要。在此,我们综述非典型股骨骨折的流行病学、危险因素、治疗选择及发病机制。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/6722257/0006fbf03e5c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/6722257/68b89b1fecc9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/6722257/0006fbf03e5c/gr2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/6722257/68b89b1fecc9/gr1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/2d46/6722257/0006fbf03e5c/gr2.jpg

相似文献

1
Atypical femoral fractures from bisphosphonate in cancer patients - Review.癌症患者使用双膦酸盐类药物导致的非典型股骨骨折——综述
J Bone Oncol. 2019 Aug 22;18:100259. doi: 10.1016/j.jbo.2019.100259. eCollection 2019 Oct.
2
Atypical fractures at non-classical sites associated with anti-resorptive therapy: a systematic review.与抗吸收治疗相关的非典型部位非典型骨折:一项系统综述。
J Bone Miner Res. 2024 Nov 29;39(12):1722-1734. doi: 10.1093/jbmr/zjae159.
3
Atypical femur fractures among breast cancer and multiple myeloma patients receiving intravenous bisphosphonate therapy.接受静脉用双膦酸盐治疗的乳腺癌和多发性骨髓瘤患者中的非典型股骨骨折。
Bone. 2012 Sep;51(3):524-7. doi: 10.1016/j.bone.2012.05.010. Epub 2012 May 23.
4
Atypical subtrochanteric and diaphyseal femoral fractures: report of a task force of the American Society for Bone and Mineral Research.非典型转子下和骨干股骨骨折:美国骨矿研究学会工作组报告。
J Bone Miner Res. 2010 Nov;25(11):2267-94. doi: 10.1002/jbmr.253.
5
Incidence and medical management of bisphosphonate-associated atypical femoral fractures in a major trauma centre: a retrospective observational study.一家大型创伤中心双膦酸盐相关非典型股骨骨折的发病率及医疗处理:一项回顾性观察研究
BMC Musculoskelet Disord. 2017 Jan 23;18(1):29. doi: 10.1186/s12891-017-1392-9.
6
Bisphosphonate-associated atypical sub-trochanteric femur fractures: paired bone biopsy quantitative histomorphometry before and after teriparatide administration.双膦酸盐相关性非典型转子下股骨骨折:特立帕肽治疗前后配对骨活检定量组织形态计量学研究。
Semin Arthritis Rheum. 2015 Apr;44(5):477-482. doi: 10.1016/j.semarthrit.2014.09.005. Epub 2014 Sep 16.
7
The Sydney AFF Score: A Simple Tool to Distinguish Females Presenting With Atypical Femur Fractures Versus Typical Femur Fractures.悉尼 AFF 评分:一种简单的工具,用于区分表现为非典型股骨骨折与典型股骨骨折的女性。
J Bone Miner Res. 2021 May;36(5):910-920. doi: 10.1002/jbmr.4255. Epub 2021 Feb 16.
8
Current concepts in the management of bisphosphonate associated atypical femoral fractures.双膦酸盐相关非典型股骨骨折治疗的当前概念
World J Orthop. 2021 Sep 18;12(9):660-671. doi: 10.5312/wjo.v12.i9.660.
9
Retrospective Review of Atypical Femoral Fracture in Metastatic Bone Disease Patients Receiving Denosumab Therapy.接受地诺单抗治疗的转移性骨病患者非典型股骨骨折的回顾性研究
Oncologist. 2017 Apr;22(4):438-444. doi: 10.1634/theoncologist.2016-0192. Epub 2017 Mar 8.
10
Risk of complete atypical femur fracture with Oral bisphosphonate exposure beyond three years.口服双膦酸盐暴露超过 3 年时发生完全非典型股骨骨折的风险。
BMC Musculoskelet Disord. 2020 Dec 3;21(1):801. doi: 10.1186/s12891-020-03672-w.

引用本文的文献

1
Risk of Osteonecrosis of the Jaw in Patients Treated with Zoledronic or Alendronic Acid: A Systematic Review.接受唑来膦酸或阿仑膦酸治疗的患者发生颌骨坏死的风险:一项系统评价
Medicina (Kaunas). 2025 Jun 26;61(7):1159. doi: 10.3390/medicina61071159.
2
Atypical Femoral Fracture During Long-Term Treatment With Denosumab in Patients With Metastatic Bone Tumors.地诺单抗长期治疗转移性骨肿瘤患者期间的非典型股骨骨折
Cureus. 2025 May 29;17(5):e85052. doi: 10.7759/cureus.85052. eCollection 2025 May.
3
Atypical Femoral Fracture in Patients With Metastatic Bone Tumors: An Analysis Based on the Japanese Adverse Drug Event Reaction Database (JADER).

本文引用的文献

1
Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.辅助地舒单抗用于激素受体阳性乳腺癌(ABCSG-18)绝经后患者:一项随机、双盲、安慰剂对照、3 期临床试验的无病生存结果。
Lancet Oncol. 2019 Mar;20(3):339-351. doi: 10.1016/S1470-2045(18)30862-3. Epub 2019 Feb 19.
2
Mechanisms Underlying Normal Fracture Healing and Risk Factors for Delayed Healing.正常骨折愈合的机制和延迟愈合的危险因素。
Curr Osteoporos Rep. 2019 Feb;17(1):36-47. doi: 10.1007/s11914-019-00501-5.
3
Indirect Evaluation of Bone Saturation with Zoledronic Acid After Long-Term Dosing.
转移性骨肿瘤患者的非典型股骨骨折:基于日本药品不良反应数据库(JADER)的分析
Cureus. 2025 May 14;17(5):e84126. doi: 10.7759/cureus.84126. eCollection 2025 May.
4
Atypical Femur Fracture in a Teenager on Chronic Imatinib Therapy.一名接受慢性伊马替尼治疗的青少年发生非典型股骨骨折。
Case Rep Oncol Med. 2025 Jan 6;2025:2081905. doi: 10.1155/crom/2081905. eCollection 2025.
5
Latent metabolic bone disease, skeletal dysplasia and other conditions related to low bone formation among 38 patients with subtrochanteric femoral fractures: a retrospective observational study.38 例股骨转子下骨折患者的潜在代谢性骨病、骨骼发育不良和其他低骨形成相关情况:一项回顾性观察研究。
Osteoporos Int. 2024 Sep;35(9):1633-1643. doi: 10.1007/s00198-024-07168-4. Epub 2024 Jul 1.
6
Differences in bone histomorphometry between White postmenopausal women with and without atypical femoral fracture after long-term bisphosphonate therapy.长期双膦酸盐治疗后,白种绝经后妇女中有无非典型股骨骨折的骨组织形态计量学差异。
J Bone Miner Res. 2024 May 2;39(4):417-424. doi: 10.1093/jbmr/zjae018.
7
Factors Affecting the Second Complete Atypical Femoral Fracture after the First Atypical Fracture.影响第一次非典型性骨折后第二次完全非典型性骨折的因素。
Med Princ Pract. 2024;33(1):10-20. doi: 10.1159/000535759. Epub 2023 Dec 15.
8
Prevalence of Precursory Signs of Atypical Femoral Fractures in Patients Receiving Bone-Modifying Agents for Bone Metastases: A Cross-Sectional Study.接受骨改良药物治疗骨转移患者非典型股骨骨折前驱症状的患病率:一项横断面研究。
JBMR Plus. 2023 Apr 27;7(7):e10749. doi: 10.1002/jbm4.10749. eCollection 2023 Jul.
9
Association of oral bisphosphonates with cardioembolic ischemic stroke: a nested case-control study.口服双膦酸盐与心源性栓塞性缺血性卒中的关联:一项巢式病例对照研究。
Front Pharmacol. 2023 May 26;14:1197238. doi: 10.3389/fphar.2023.1197238. eCollection 2023.
10
A Facile Crystallization Strategy to Turn Calcium Bisphosphonates into Novel Osteogenesis-Inducing Biomaterials.一种将双膦酸盐转化为新型成骨诱导生物材料的简便结晶策略。
Adv Healthc Mater. 2023 Sep;12(22):e2203004. doi: 10.1002/adhm.202203004. Epub 2023 Jun 7.
唑来膦酸长期给药后骨饱和度的间接评估。
Oncologist. 2019 Feb;24(2):178-184. doi: 10.1634/theoncologist.2018-0218. Epub 2018 Oct 8.
4
Genetic Risk Factors for Atypical Femoral Fractures (AFFs): A Systematic Review.非典型股骨骨折(AFFs)的遗传风险因素:一项系统综述
JBMR Plus. 2018 Jan 3;2(1):1-11. doi: 10.1002/jbm4.10024. eCollection 2018 Jan.
5
Atypical Femur Fractures: Review of Epidemiology, Relationship to Bisphosphonates, Prevention, and Clinical Management.非典型股骨骨折:流行病学综述、与双膦酸盐的关系、预防及临床处理。
Endocr Rev. 2019 Apr 1;40(2):333-368. doi: 10.1210/er.2018-00001.
6
Atypical femoral fractures and current management.非典型股骨骨折与当前治疗方法
J Orthop Translat. 2016 Jul 5;7:7-22. doi: 10.1016/j.jot.2016.06.029. eCollection 2016 Oct.
7
Current Understanding of Epidemiology, Pathophysiology, and Management of Atypical Femur Fractures.对非典型股骨骨折的流行病学、病理生理学和治疗的现有认识。
Curr Osteoporos Rep. 2018 Aug;16(4):519-529. doi: 10.1007/s11914-018-0464-6.
8
MANAGEMENT OF ENDOCRINE DISEASE: Atypical femoral fractures: risks and benefits of long-term treatment of osteoporosis with anti-resorptive therapy.内分泌疾病管理:非典型股骨骨折:抗吸收疗法长期治疗骨质疏松症的风险与益处
Eur J Endocrinol. 2018 Mar;178(3):R81-R87. doi: 10.1530/EJE-17-1002. Epub 2018 Jan 16.
9
Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial.MAF 扩增对早期乳腺癌辅助唑来膦酸治疗结局的影响:国际、开放标签、随机、对照、III 期 AZURE(BIG 01/04)试验的二次分析。
Lancet Oncol. 2017 Nov;18(11):1543-1552. doi: 10.1016/S1470-2045(17)30603-4. Epub 2017 Oct 13.
10
Predisposing factors associated with atypical femur fracture among postmenopausal Korean women receiving bisphosphonate therapy: 8 years' experience in a single center.接受双膦酸盐治疗的绝经后韩国女性发生非典型股骨骨折的相关易感因素:单中心 8 年经验。
Osteoporos Int. 2017 Nov;28(11):3251-3259. doi: 10.1007/s00198-017-4169-y. Epub 2017 Jul 27.